Social engagement
Social engagement: 543 social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |
Biotech developing novel anti-inflammatory therapies for immune-driven diseases
Social engagement: 543 social following, 1 post in the last 12 months — below the industry typical range.
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |